Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

FDA Expands Evolut Indication to Include Redo TAVI

News Daily News

FDA Expands Evolut Indications to Include Redo TAVI

Yael L. Maxwell

August 29, 2025

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

FDA Approves Portico TAVI Valve, Paving the Way for Third US Device

News Daily News

FDA Approves Portico TAVI Valve, Paving the Way for Third US Device

September 20, 2021

Sapien 3 Valve Approved in Europe for Low-Risk Patients

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

FDA Expands TAVR Indication to Low-Risk Patients

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

FDA Approves Lotus Edge, Ushering Third Device Into US Market

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

April 24, 2019

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Michael O'Riordan

July 10, 2017

News Daily News

FDA Approves Next-Gen CoreValve Evolut PRO Valve

March 22, 2017

News Daily News

FDA Approves 34-mm TAVR Valve for Patients With Larger Anatomy

October 27, 2016

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Michael O'Riordan

September 20, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

News Daily News

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

August 01, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.